re: Ann: FDA agrees on potential regulatory p... Still going ahead as planned.
Taken from today's announcement:
ChemGenex is continuing its discussions with the FDA?s Center for Devices and Radiological Health towards approval of a diagnostic test for the T315I mutation, and the existing NDA for T315I positive CML patients who have failed imatinib remains open.
- Forums
- ASX - By Stock
- CXS
- Ann: FDA agrees on potential regulatory pathway f
Ann: FDA agrees on potential regulatory pathway f, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online